Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease.
Наслов
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease.
Идентификатор
/unibl/sci/idNaucniRad:23027
Тип
Пронађите сличне уносеAcademic Article
Датум
Пронађите сличне уносе2016-06
Библиографски цитат
J. Escaned, A. Banning, V. Farooq, M. Echavarria-Pinto, Y. Onuma, N. Ryan, R. Calvacante, C. Campos, B. Stanetić, Y. Ishibashi, P. Suwannasom, A. Kappetein, D. Taggart, M. Morel, G. van Es, P. Serruys, Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease., EuroIntervention, Vol. 12, No. 2, pp. 224 - 234, Jun, 2016
Почетна страница
224
Крајња страница
234
Је дио
Пронађите сличне уносеEuroIntervention
Пронађите сличне уносе1969-6213
Листа аутора
Position: 411 (61 views)